Autoantibodies against C-reactive protein (CRP) in sera of patients with systemic rheumatic diseases

Modern Rheumatology

Volumn 11, Issue 2, 2001, Pages 127-131

  Minatani, Megumi ^a,b   Aotsuka, Shinichi ^b   Satoh, Tetsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Anti CRP antibodies; C reactive protein; Modified CRP; Systemic lupus erythematosus; Systemic rheumatic disease

Indexed keywords

EID: 33747187398     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s101650170023     Document Type: Article

References (26)

1. Robey FA, Jones KD, Steinberg AD. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J Exp Med 1985;161:1433-56.
2. Bell SA, Du Clos TW, Khursigara G, Picazo JJ, Rubin RL. Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmun 1995;8:293-303.
3. Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 1998;113:327-32.
4. Kushner I. The acute phase response: an overview. Methods Enzymol 1988;163:373-99.
5. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
6. Motie M, Brockmeier S, Potempa LA. Binding of model soluble immune complexes to modified C-reactive protein. J Immunol 1996;156:4435-41.
7. Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H. Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol Immunol 1987;24:531-41.
8. Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 1988;12:391-405.
9. Potempa LA, Motie M, Wright KE, Crump BL, Radosevich JA, Sakai N, et al. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP). Exp Hematol 1996;24:258-63.
10. Bray RA, Samberg NL, Gewurz H, Potempa LA, Landay AL. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. J Immunol 1988;140:4271-8.
11. Rees RF, Gewurz H, Siegel JN, Coon J, Potempa LA. Expression of C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Clin Immunol Immunopathol 1988;48:95-107.
12. Kolb-Bachofen V, Puchta-Teudt N, Egenhofer C. Expression of membrane-associated C-reactive protein by human monocytes: indications for a selectin-like activity participating in adhesion. Glycoconj J 1995;12:122-7.
13. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Arthritis Rheum 1980;23:581-90.
16. Manthopre R, Oxholm P, Prause JT, Schiodt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986;61 Suppl:19-21.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7, 403-7.
18. Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R. Clinical features of patients with juvenile-onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol 1996;23:1088-94.
19. Koffler D, Agnello V, Thoburn R, Kunkel HG. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 1971;134 Suppl:169s+.
20. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993;20:815-21.
21. Lacki JK, Leszczynski P, Kelemen J, Muller W, Mackiewicz SH. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response. J Med 1997;28:99-107.
22. Du Clos TW, Zlock LT, Rubin RL. Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 1988;141:4266-70.
23. Du Clos TW. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 1989;143:2553-9.
24. Biggiogera M, Bottone MG, Martin TE, Uchiumi T, Pellicciari C. Still immunodetectable nuclear RNPs are extruded from the cytoplasm of spontaneously apototic thymocytes. Exp Cell Res 1997;234:512-20.
25. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-61.
26. Topfer F, Gordon T, McCluskey J. Intra-and intermolecular spreading of autoimmunity involving the nuclear self-antigen La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995;92:875-9.